Beck Capital Management’s Celgene Corp CELG Stock Holding History

Beck Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,585	Closed	-$1.28M	–	121
2019 Q1	$1.28M	Buy	13,585 +365	+3%	+$31.9K	0.61%	51
2018 Q4	$847K	Buy	+13,220	New	+$976K	0.73%	36
2015 Q3	–	Sell	-1,810	Closed	-$209K	–	160
2015 Q2	$209K	Buy	1,810 +50	+3%	+$5.72K	0.11%	133
2015 Q1	$203K	Sell	1,760 -165	-9%	-$19.7K	0.12%	132
2014 Q4	$215K	Buy	+1,925	New	+$203K	0.13%	139

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Beck Capital Management's CELG Position: Q2 2019 in Review

Beck Capital Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 13,585 shares — an estimated $1.28M sold.

Beck Capital Management first reported a position in CELG in Q4 2014 and held it in 5 quarters. The position peaked at $1.28M in Q1 2019. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Beck Capital Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Beck Capital Management sold 13,585 Celgene Corp shares in Q2 2019, an estimated $1.28M.
Beck Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 5 quarters.
Beck Capital Management's Celgene Corp position peaked at $1.28M in Q1 2019.
1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Beck Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.